Barbara Allen - DR Horton Independent Director
| DHI Stock | USD 172.94 9.41 5.75% |
Director
Ms. Barbara K. Allen is an Independent director of the Company. Ms. Allen has significant experience researching, analyzing and making investment decisions related to housingrelated companies. Ms. Allen retired from Avondale Partners in July 2006 where she was a Partner and Housing, Construction and Retailing Analyst. From February 1997 through December 2004, she was the Home Construction, Building Materials, Home Furnishing and DIY Retailing Analyst for Natexis Bleichroeder, Inc. Ms. Allen was a Vice President, Equity Research for Donaldson, Lufkin Jenrette from January 1993 through January 1996. She served in other roles at Oppenheimer Company, Kidder, Peabody, Inc., and Prudential Securities prior to January 1993. Ms. Allen was a member of the Audit, Compensation and Nominating and Governance Committees since 2014. Ms. Allens extensive experience working as an analyst and consultant with housingrelated companies provides valuable knowledge to the Board with regard to strategic decisions, including investment, operating and financing matters. since 2014.
| Age | 74 |
| Tenure | 10 years |
| Address | 1341 Horton Circle, Arlington, TX, United States, 76011 |
| Phone | 817 390 8200 |
| Web | https://www.drhorton.com |
Barbara Allen Latest Insider Activity
Tracking and analyzing the buying and selling activities of Barbara Allen against DR Horton stock is an integral part of due diligence when investing in DR Horton. Barbara Allen insider activity provides valuable insight into whether DR Horton is net buyers or sellers over its current business cycle. Note, DR Horton insiders must abide by specific rules, including filing SEC forms every time they buy or sell DR Horton'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Barbara Allen over three months ago Disposition of 363 shares by Barbara Allen of DR Horton at 148.46 subject to Rule 16b-3 |
DR Horton Management Efficiency
The company has Return on Asset of 0.1113 % which means that on every $100 spent on assets, it made $0.1113 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1963 %, implying that it generated $0.1963 on every 100 dollars invested. DR Horton's management efficiency ratios could be used to measure how well DR Horton manages its routine affairs as well as how well it operates its assets and liabilities. As of now, DR Horton's Return On Capital Employed is increasing as compared to previous years. The DR Horton's current Return On Equity is estimated to increase to 0.35, while Return On Tangible Assets are projected to decrease to 0.1. As of now, DR Horton's Total Current Assets are increasing as compared to previous years. The DR Horton's current Other Assets is estimated to increase to about 6.3 B, while Non Currrent Assets Other are forecasted to increase to (159.1 M).Similar Executives
| Showing other executives | DIRECTOR Age | ||
| William Rosier | NVR Inc | 72 | |
| Carl Marbach | Toll Brothers | 79 | |
| Joseph Keough | Meritage | 51 | |
| Melissa Lora | KB Home | 58 | |
| Robert Coutts | Hovnanian Enterprises | 71 | |
| Norma Provencio | Beazer Homes USA | 63 | |
| Janet Jackson | Installed Building Products | 67 | |
| John McLean | Toll Brothers | 51 | |
| Deborah Henretta | Meritage | 59 | |
| Robert Johnson | KB Home | 74 | |
| Larry Sorsby | Hovnanian Enterprises | 69 | |
| Karen Grimes | Toll Brothers | 64 | |
| Elizabeth Acton | Beazer Homes USA | 69 | |
| Scott Stowell | Lennar | 62 | |
| Timothy Finchem | KB Home | 73 | |
| Dorene Dominguez | KB Home | 58 | |
| Joseph Marengi | Hovnanian Enterprises | 67 | |
| Susan Ross | NVR Inc | 59 | |
| Michael Wood | KB Home | 72 | |
| David Meuse | Installed Building Products | 74 | |
| Andre Hawaux | PulteGroup | 60 | |
Management Performance
DR Horton Leadership Team
Elected by the shareholders, the DR Horton's board of directors comprises two types of representatives: DR Horton inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DHI. The board's role is to monitor DR Horton's management team and ensure that shareholders' interests are well served. DR Horton's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DR Horton's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael Buchanan, Independent Director | ||
| Donald Horton, Executive Chairman of the Board | ||
| Maribess Miller, Independent Director | ||
| Michael Hewatt, Independent Director | ||
| Michael Murray, Co-Chief Operating Officer, Executive Vice President | ||
| Thomas Montano, Corporate VP | ||
| Aron Odom, Principal Accounting Officer | ||
| Tom Hill, President Region | ||
| Jessica Hansen, VP of Communications | ||
| Barbara Allen, Independent Director | ||
| David Auld, President, Chief Executive Officer | ||
| Bill Wheat, Chief Financial Officer, Executive Vice President | ||
| Paul Romanowski, Co-Chief Operating Officer, Executive Vice President | ||
| Benjamin Carson, Independent Director | ||
| Collin Dawson, Vice Treasurer | ||
| Bradley Anderson, Independent Director | ||
| Matt Farris, President Region |
DHI Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is DR Horton a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.2 | ||||
| Return On Asset | 0.11 | ||||
| Profit Margin | 0.13 % | ||||
| Operating Margin | 0.17 % | ||||
| Current Valuation | 53.98 B | ||||
| Shares Outstanding | 321.17 M | ||||
| Shares Owned By Insiders | 10.34 % | ||||
| Shares Owned By Institutions | 83.45 % | ||||
| Number Of Shares Shorted | 6.19 M | ||||
| Price To Earning | 5.10 X |
Currently Active Assets on Macroaxis
When determining whether DR Horton offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DR Horton's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dr Horton Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dr Horton Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DR Horton. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For more detail on how to invest in DHI Stock please use our How to Invest in DR Horton guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Household Durables space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DR Horton. If investors know DHI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DR Horton listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.12) | Dividend Share 1.2 | Earnings Share 14.34 | Revenue Per Share 111.689 | Quarterly Revenue Growth (0.05) |
The market value of DR Horton is measured differently than its book value, which is the value of DHI that is recorded on the company's balance sheet. Investors also form their own opinion of DR Horton's value that differs from its market value or its book value, called intrinsic value, which is DR Horton's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DR Horton's market value can be influenced by many factors that don't directly affect DR Horton's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DR Horton's value and its price as these two are different measures arrived at by different means. Investors typically determine if DR Horton is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DR Horton's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.